Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

First approval obtained for Cialis

Nov. 15, 2002

Novel substance P antagonists covered by Takeda patent

Nov. 15, 2002

New 5-HT2C agonists for erectile dysfunction and other disorders under study at Yamanouchi

Nov. 15, 2002

Accelerated approval plan for KRX-101

Nov. 14, 2002

Positive results from TA-1790 erectile dysfunction study

Nov. 13, 2002

Health Canada approves irbesartan for diabetic renal disease

Nov. 13, 2002

New PDE5 inhibitors in early development at Pfizer

Nov. 13, 2002

Series of PDE5 inhibitors in early development at Tanabe Seiyaku

Nov. 11, 2002

Potential of GPI-1046 for maintaining erectile function after radical prostatectomy

Nov. 6, 2002

Prostanoid IP antagonists and their use in bladder disorders reported by Roche

Nov. 6, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...